Medite Cancer Diagnostics, Inc.
Medite Cancer Diagnostics, Inc. (MDIT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MDIT · as of Jun 8, 2026
Key Statistics
Explore Medite Cancer Diagnostics, Inc. Data
mdit stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
mdit competitorsMDIT
ASFX
CEVE
FIORF
HSMD
LOWLFStock Performance
Full HistoryAbout Medite Cancer Diagnostics, Inc.
Medite Cancer Diagnostics, Inc. functions as a specialized medical technology enterprise focused on the development, manufacturing, and commercialization of molecular biomarkers, sophisticated medical…
what is medite cancer diagnostics, inc. · mdit stock overview · medite cancer diagnostics, inc. company profile · who is medite cancer diagnostics, inc. ceo · mdit OTC · medite cancer diagnostics, inc. headquarters · medite cancer diagnostics, inc. business segments
About Stock Overview & Key Data
Medite Cancer Diagnostics, Inc. (MDIT) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on OTC since Feb 2, 1995. As of the latest trading session, MDIT stock price is $0.00, with a market capitalization of $8,672. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2017, Medite Cancer Diagnostics, Inc. reported revenue of $6.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Medite Cancer Diagnostics, Inc. (MDIT) stock price is $0.00. The stock is traded on OTC under the ticker symbol MDIT. The 52-week range is $0.00 – $0.01.